CN101810745B - Plaster for treating hyperplasia of mammary glands - Google Patents

Plaster for treating hyperplasia of mammary glands Download PDF

Info

Publication number
CN101810745B
CN101810745B CN2010101383563A CN201010138356A CN101810745B CN 101810745 B CN101810745 B CN 101810745B CN 2010101383563 A CN2010101383563 A CN 2010101383563A CN 201010138356 A CN201010138356 A CN 201010138356A CN 101810745 B CN101810745 B CN 101810745B
Authority
CN
China
Prior art keywords
radix
rhizoma
parts
plaster
cortex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010101383563A
Other languages
Chinese (zh)
Other versions
CN101810745A (en
Inventor
荣彩霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010101383563A priority Critical patent/CN101810745B/en
Publication of CN101810745A publication Critical patent/CN101810745A/en
Application granted granted Critical
Publication of CN101810745B publication Critical patent/CN101810745B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a plaster for treating hyperplasia of mammary glands, and belongs to a pure Chinese medicinal preparation. The plaster comprises the following components in part by weight: 4 to 8 parts of astragalus, 1 to 5 parts of largehead atractylodes rhizome, 1 to 5 parts of gleditsia thorn, 1 to 5 parts of pinellia tuber, 1 to 6 parts of officinal magnolia bark, 1 to 5 parts of Chinese angelica, 1 to 5 parts of cassia bark, 1 to 5 parts of nutgrass galingale rhizome, 1 to 5 parts of costustoot, 1 to 5 parts of raw rehmannia root, 1 to 5 parts of rhubarb, 1 to 5 parts of root ofred-rooted salvia, 1 to 5 parts of bitter orange, 1 to 5 parts of liquoric root, 400 to 600 parts of pure soybean oil and an appropriate amount of starch. A method for preparing the plaster comprises the following steps of: soaking the medicaments into the pure soybean oil; putting the medicaments into a sandy pot after soaking for enough days; decocting the medicaments over slow fire until the medicaments are dried and floated; filtering gruffs off with disinfected white cloth to prepare medicinal oil; making the ratio of the medicinal oil to the starch be 2:1; decocting the mixture over slow fire; continuously stirring the mixture until the mixture becomes sticky; dropping the mixture into water to become beads; collecting the beads into a porcelain container; and soaking the porcelain container into cold water for later use. The plaster has the effects of soothing liver and relieving depression, regulating vital energy and relieving pain, freeing network vessels and diminishing inflammation, and activating blood to dissipate stagnation because of compatibility of all the Chinese medicaments, and has obvious curative effect of treating the hyperplasia of mammary glands and over 80 percent of cure rate.

Description

A kind of plaster of treating cyclomastopathy
Technical field
The present invention relates to a kind of external Chinese medicine, exactly is a kind of plaster of treating cyclomastopathy and mammary gland tumor, belongs to Chinese medicine preparation and applied technical field.
Background technology
Cyclomastopathy is common gynecological disease, see disease more.The method of treatment cyclomastopathy is main with Drug therapy mainly at present, and doctor trained in Western medicine adopts hormone therapy, but the hormone therapy cycle is long, and relapse rate is high, and side effect is big; Domestic many employing treatments by Chinese herbs, but curative effect is not ideal enough again.
Summary of the invention
The objective of the invention is deficiency, and a kind of plaster with treatment cyclomastopathy of dispersing the stagnated live-QI to relieve the stagnation of QI and transforming phlegm and dispersing accumulations effect is provided to above-mentioned prior art.This product belongs to pure Chinese medicinal preparation, and it is to carry out the drug osmotic treatment through skin surface.It contains following Chinese medicine ingredients: the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Spina Gleditsiae, the Rhizoma Pinelliae, Cortex Magnoliae Officinalis, Radix Angelicae Sinensis, Cortex cinnamomi japonici (Ramulus Cinnamomi), Rhizoma Cyperi, the Radix Aucklandiae, Radix Rehmanniae, Radix Et Rhizoma Rhei, Radix Salviae Miltiorrhizae, Fructus Aurantii, Radix Glycyrrhizae and true yellow Oleum Glycines and decide powder.Above-mentioned each composition weight share preparation: Radix Astragali 4-8; Rhizoma Atractylodis Macrocephalae 1-5; Spina Gleditsiae 1-5; Rhizoma Pinelliae 1-5; Cortex Magnoliae Officinalis 1-6; Radix Angelicae Sinensis 1-5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1-5; Rhizoma Cyperi 1-5; Radix Aucklandiae 1-5; Radix Rehmanniae 1-5; Radix Et Rhizoma Rhei 1-5; Radix Salviae Miltiorrhizae 1-5; Fructus Aurantii 1-5; Radix Glycyrrhizae 1-5 and true yellow Oleum Glycines 400-600 are with to decide powder an amount of.
Above-mentioned Chinese medicine is made as follows: with true yellow Oleum Glycines medicine is soaked in the oil, soak time is 5 days springs, 3 days summers, 5 days autumns, 10 days winters.Wait to soak day full after, put it in the black earth pot, slow fire endures that to make medicine withered, floats to medicine, filters gruffs with the sterilization calico then, makes medicine oil.To going into to decide powder, the slow fire of useing force boils with medicine oil, and ceaselessly stirs with Ramulus Persicae, Ramulus Salicis Babylonicae, Ramulus Mori or Rumalus sophorae, treats that plaster like China ink as lacquer, splashes into Cheng Zhu in the water, takes in the porcelain then, and porcelain is put into cold water, soaks seven days, and releasing fire-toxin is subsequent use.
The present invention has significant curative effect for the treatment cyclomastopathy, and it adds the Radix Astragali with invigorating QI to consolidate the body surface resistance, expelling pus and toxin by strengthening QI, diuresis, granulation promoting in prescription; Have spleen reinforcing, stomach reinforcing, dampness and in, the dehumidifying benefit is dry, the Rhizoma Atractylodis Macrocephalae that quenches the thirst; Have and return liver, stomach through, evacuation of pus and the promoting blood circulation and detumescence effect of drawing out pus by applying a plaster to the affected part and be used for that carbuncle, sore, pus become to burst, the Spina Gleditsiae of scabies; The Rhizoma Pinelliae with drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass and externally used detumescence analgesic effect; Have dampness expectorant, the therapeutic method to keep the adverse QI flowing downwards except that full Cortex Magnoliae Officinalis; Have benefiting blood and regulating blood circulation, moisturize that laxation 、 mass in the abdomen knot gathers, metrorrhagia, headache due to deficiency of blood, dizzy, flaccidity syndrome and arthralgia syndrome, dryness of the intestine dyschezia, the carbuncle skin ulcer is stolen and the Radix Angelicae Sinensis of traumatic injury effect; Have warming the spleen and stomach, dispersing wind and cold, promoting blood circulation effect and, rheumatic arthralgia dysphagic, fall and decrease the stasis of blood and stagnate the Cortex cinnamomi japonici (Ramulus Cinnamomi) of significant curative effect is arranged vomitting; Has liver-smoothing, qi-regulating, the Rhizoma Cyperi of menstruction regulating and pain relieving; Have promoting the circulation of QI to relieve pain, strengthening the spleen to promote digestion effect, be mainly used in heavy behind breast gastral cavity distending pain, the dysentery, food stagnation does not disappear, the Radix Aucklandiae of anorexia; Have clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting effect, cure mainly that YIN damaged by pathogenic heat, crimson tongue excessive thirst, interior-heat caused by deficiency of YIN, night fever abating at dawn, hectic fever due to YIN-deficiency consumptive fever, interior-heat are quenched one's thirst, the Radix Rehmanniae of hematemesis and epistaxis and maculopapulae due to toxic heat; Has stimulate the menstrual flow effect and be used for the Radix Et Rhizoma Rhei of traumatic injury, swelling and pain due to blood stasis, removing damp-heat, cooling blood for hemostasis of removing toxicity for eliminating carbuncles, clots absorbing; Has the Radix Salviae Miltiorrhizae that promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle and relieving restlessness are calmed the nerves; Have regulating the flow of QI to ease the stomach, the stagnant relieving distension effect of row also is used for the breast side of body stagnation of QI, distension pain, the Fructus Aurantii of accumulation of food in the stomach and intes tine due to indigestion and the Radix Glycyrrhizae with invigorating the spleen and replenishing QI, expelling phlegm for arresting cough, relieving spasm to stop pain, heat-clearing and toxic substances removing and coordinating the actions of various ingredients in a prescription effect.Also added have removing food stagnancy, parasite killing, detoxifcation and granulation promoting effect decide powder.
The present invention is a pure Chinese medicinal preparation, because the compatibility effect of each flavor Chinese medicine has the effect of dispersing the stagnated live-QI to relieve the stagnation of QI, regulating QI to relieve pain, collateral dredging antiinflammatory and blood circulation promoting and dispersing pathogen accumulation, the treatment cyclomastopathy is evident in efficacy.The present invention can directly be affixed on the affected part, the medicine sick institute that goes directly.Its advantage is: efficacy consolidation, drug effect is fast, treatment cycle is short, have no side effect, that medical expense reaches method for preparing less is simple and easy to use.Can treat and effect a radical cure cyclomastopathy effectively, its cure rate can reach more than 80%.
The specific embodiment
Embodiment 1
Present embodiment comprises: the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Spina Gleditsiae, the Rhizoma Pinelliae, Cortex Magnoliae Officinalis, Radix Angelicae Sinensis, Cortex cinnamomi japonici (Ramulus Cinnamomi), Rhizoma Cyperi, the Radix Aucklandiae, Radix Rehmanniae, Radix Et Rhizoma Rhei, Radix Salviae Miltiorrhizae, Fructus Aurantii, Radix Glycyrrhizae and true yellow Oleum Glycines and decide powder.Above-mentioned each composition weight share preparation: Radix Astragali 4-8; Rhizoma Atractylodis Macrocephalae 1-5; Spina Gleditsiae 1-5; Rhizoma Pinelliae 1-5; Cortex Magnoliae Officinalis 1-6; Radix Angelicae Sinensis 1-5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1-5; Rhizoma Cyperi 1-5; Radix Aucklandiae 1-5; Radix Rehmanniae 1-5; Radix Et Rhizoma Rhei 1-5; Radix Salviae Miltiorrhizae 1-5; Fructus Aurantii 1-5; Radix Glycyrrhizae 1-5 and true yellow Oleum Glycines 400-600 are with to decide powder an amount of.
Embodiment 2
Weight share is got Radix Astragali 4-4.5; Rhizoma Atractylodis Macrocephalae 1-1.5; Spina Gleditsiae 1-1.5; Rhizoma Pinelliae 1-1.5; Cortex Magnoliae Officinalis 1-1.5; Radix Angelicae Sinensis 1-1.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1-1.5; Rhizoma Cyperi 1-1.5; Radix Aucklandiae 1-1.5; Radix Rehmanniae 1-1.5; Radix Et Rhizoma Rhei 1-1.5; Radix Salviae Miltiorrhizae 1-1.5; Fructus Aurantii 1-1.5; Radix Glycyrrhizae 1-1.5 and true yellow Oleum Glycines 400 is with to decide powder an amount of.
Embodiment 3
Weight share is got Radix Astragali 4.5-5; Rhizoma Atractylodis Macrocephalae 1.5-2; Spina Gleditsiae 1.5-2; Rhizoma Pinelliae 1.5-2; Cortex Magnoliae Officinalis 1.5-2; Radix Angelicae Sinensis 1.5-2; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1.5-2; Rhizoma Cyperi 1.5-2; Radix Aucklandiae 1.5-2; Radix Rehmanniae 1.5-2; Radix Et Rhizoma Rhei 1.5-2; Radix Salviae Miltiorrhizae 1.5-2; Fructus Aurantii 1.5-2; Radix Glycyrrhizae 1.5-2 and true yellow Oleum Glycines 500 is with to decide powder an amount of.
Embodiment 4
Weight share is got Radix Astragali 5-5.5; Rhizoma Atractylodis Macrocephalae 2-2.5; Spina Gleditsiae 2-2.5; Rhizoma Pinelliae 2-2.5; Cortex Magnoliae Officinalis 2-2.5; Radix Angelicae Sinensis 2-2.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 2-2.5; Rhizoma Cyperi 2-2.5; Radix Aucklandiae 2-2.5; Radix Rehmanniae 2-2.5; Radix Et Rhizoma Rhei 2-2.5; Radix Salviae Miltiorrhizae 2-2.5; Fructus Aurantii 2-2.5; Radix Glycyrrhizae 2-2.5 and true yellow Oleum Glycines 500 is with to decide powder an amount of.
Embodiment 5
Weight share is got Radix Astragali 5.5-6; Rhizoma Atractylodis Macrocephalae 2.5-3; Spina Gleditsiae 2.5-3; Rhizoma Pinelliae 2.5-3; Cortex Magnoliae Officinalis 2.5-3; Radix Angelicae Sinensis 2.5-3; Cortex cinnamomi japonici (Ramulus Cinnamomi) 2.5-3; Rhizoma Cyperi 2.5-3; Radix Aucklandiae 2.5-3; Radix Rehmanniae 2.5-3; Radix Et Rhizoma Rhei 2.5-3; Radix Salviae Miltiorrhizae 2.5-3; Fructus Aurantii 2.5-3; Radix Glycyrrhizae 2.5-3 and true yellow Oleum Glycines 500 is with to decide powder an amount of.
Embodiment 6
Weight share is got Radix Astragali 6-6.5; Rhizoma Atractylodis Macrocephalae 3-3.5; Spina Gleditsiae 3-3.5; Rhizoma Pinelliae 3-3.5; Cortex Magnoliae Officinalis 3-3.5; Radix Angelicae Sinensis 3-3.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 3-3.5; Rhizoma Cyperi 3-3.5; Radix Aucklandiae 3-3.5; Radix Rehmanniae 3-3.5; Radix Et Rhizoma Rhei 3-3.5; Radix Salviae Miltiorrhizae 3-3.5; Fructus Aurantii 3-3.5; Radix Glycyrrhizae 3-3.5 and true yellow Oleum Glycines 550 is with to decide powder an amount of.
Embodiment 7
Weight share is got Radix Astragali 6.5-7; Rhizoma Atractylodis Macrocephalae 3.5-4; Spina Gleditsiae 3.5-4; Rhizoma Pinelliae 3.5-4; Cortex Magnoliae Officinalis 3.5-4; Radix Angelicae Sinensis 3.5-4; Cortex cinnamomi japonici (Ramulus Cinnamomi) 3.5-4; Rhizoma Cyperi 3.5-4; Radix Aucklandiae 3.5-4; Radix Rehmanniae 3.5-4; Radix Et Rhizoma Rhei 3.5-4; Radix Salviae Miltiorrhizae 3.5-4; Fructus Aurantii 3.5-4; Radix Glycyrrhizae 3.5-4 and true yellow Oleum Glycines 550 is with to decide powder an amount of.
Embodiment 8
Weight share is got Radix Astragali 7-7.5; Rhizoma Atractylodis Macrocephalae 4-4.5; Spina Gleditsiae 4-4.5; Rhizoma Pinelliae 4-4.5; Cortex Magnoliae Officinalis 4-4.5; Radix Angelicae Sinensis 4-4.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 4-4.5; Rhizoma Cyperi 4-4.5; Radix Aucklandiae 4-4.5; Radix Rehmanniae 4-4.5; Radix Et Rhizoma Rhei 4-4.5; Radix Salviae Miltiorrhizae 4-4.5; Fructus Aurantii 4-4.5; Radix Glycyrrhizae 4-4.5 and true yellow Oleum Glycines 550 is with to decide powder an amount of.
Embodiment 9
Weight share is got Radix Astragali 7.5-8; Rhizoma Atractylodis Macrocephalae 4.5-5; Spina Gleditsiae 4.5-5; Rhizoma Pinelliae 4.5-5; Cortex Magnoliae Officinalis 4.5-5; Radix Angelicae Sinensis 4.5-5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 4.5-5; Rhizoma Cyperi 4.5-5; Radix Aucklandiae 4.5-5; Radix Rehmanniae 4.5-5; Radix Et Rhizoma Rhei 4.5-5; Radix Salviae Miltiorrhizae 4.5-5; Fructus Aurantii 4.5-5; Radix Glycyrrhizae 4-4.5 and true yellow Oleum Glycines 550 is with to decide powder an amount of.
Embodiment 10
Get Radix Astragali 30g; Each 15g of the Rhizoma Atractylodis Macrocephalae, Spina Gleditsiae, the Rhizoma Pinelliae, Cortex Magnoliae Officinalis, Radix Angelicae Sinensis, Cortex cinnamomi japonici (Ramulus Cinnamomi), Rhizoma Cyperi, the Radix Aucklandiae, Radix Rehmanniae, Radix Et Rhizoma Rhei, Radix Salviae Miltiorrhizae, Fructus Aurantii and Radix Glycyrrhizae; True yellow Oleum Glycines 2500g is with to decide powder an amount of.
Make the plaster like the described treatment cyclomastopathy of embodiment 1-10, its manufacture method is described below:
To make as follows by the Chinese medicine of above-mentioned weight proportion: with true yellow Oleum Glycines medicine is soaked in the oil, soak time is 5 days springs, 3 days summers, 5 days autumns, 10 days winters.Wait to soak day full after, put it in the black earth pot, slow fire endure do medicine withered (with medicine endure withered), float to medicine, filter gruffs with the sterilization calico then, make medicine oil.To going into to decide powder 500g (deciding powder can substitute with Plumbum preparatium), promptly medicine oil is 2: 1 with the ratio of deciding powder with the every 1000g of medicine oil, and the slow fire of useing force boiled 7-8 hour; And ceaselessly splash into Cheng Zhu in the water with Ramulus Persicae, Ramulus Salicis Babylonicae, Ramulus Mori or Rumalus sophorae stirring to thick (treating that plaster is seemingly black as coating with lacquer); Take in the porcelain then, and porcelain is put into cold water, soaked seven days; Releasing fire-toxin is subsequent use.
During use, the plaster that has made is tiled on the lining cloth, sticks on the affected part then.
Clinical setting of the present invention:
Through the above hospital diagnosis of city-level, patient's 87 examples of (1) cyclomastopathy, year order is between 20 years old-50 years old; (2) patient's 21 examples of mammary gland fibroma, year order is between 18 years old-45 years old.
Cardinal symptom and sign:
(1) patient of cyclomastopathy shows mastalgia, and pain changes along with emotion and menstrual cycle and fluctuates, often before menstruation or angryly increase the weight of the menstrual onset pain relief when gloomy.
(2) patient of mammary gland fibroma is in the majority with young women; The main clinical manifestation lump in breast is not generally accompanied pain, sometimes with cyclomastopathy coexistence, the rounded or oval of adenoma; Diameter is with 1-3 centimetre; Strong but pliable in texture, clear border and skin surrounding tissue do not have adhesion, and its size does not generally change with menstrual cycle.Primary disease is generally one-sided, and primary disease must clear and definite and breast carcinoma " Differential Diagnosis ".
Medication and curative effect:
(1) patient's 87 examples of cyclomastopathy, subsides in per two days, 10 days is a course of treatment, the 79 routine patient symptoms recovery from illness that all disappears after three courses of treatment, 8 routine patient's symptoms are obviously improved.
(2) patient's 21 examples of mammary gland fibroma, subsides in per two days, 10 days is a course of treatment, and 18 routine patient's symptoms obviously alleviate after three courses of treatment, and 3 routine patients are invalid.
In sum, the present invention treats cyclomastopathy patient totally 108 examples, obvious effective rate 97.2%, and wherein cure rate is 83.6%.

Claims (10)

1. plaster of treating cyclomastopathy is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 4-8; Rhizoma Atractylodis Macrocephalae 1-5; Spina Gleditsiae 1-5; Rhizoma Pinelliae 1-5; Cortex Magnoliae Officinalis 1-6; Radix Angelicae Sinensis 1-5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1-5; Rhizoma Cyperi 1-5; Radix Aucklandiae 1-5; Radix Rehmanniae 1-5; Radix Et Rhizoma Rhei 1-5; Radix Salviae Miltiorrhizae 1-5; Fructus Aurantii 1-5; Radix Glycyrrhizae 1-5 and true yellow Oleum Glycines 400-600 are with to decide powder an amount of.
2. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 4-4.5; Rhizoma Atractylodis Macrocephalae 1-1.5; Spina Gleditsiae 1-1.5; Rhizoma Pinelliae 1-1.5; Cortex Magnoliae Officinalis 1-1.5; Radix Angelicae Sinensis 1-1.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1-1.5; Rhizoma Cyperi 1-1.5; Radix Aucklandiae 1-1.5; Radix Rehmanniae 1-1.5; Radix Et Rhizoma Rhei 1-1.5; Radix Salviae Miltiorrhizae 1-1.5; Fructus Aurantii 1-1.5; Radix Glycyrrhizae 1-1.5 and true yellow Oleum Glycines 400 is with to decide powder an amount of.
3. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 4.5-5; Rhizoma Atractylodis Macrocephalae 1.5-2; Spina Gleditsiae 1.5-2; Rhizoma Pinelliae 1.5-2; Cortex Magnoliae Officinalis 1.5-2; Radix Angelicae Sinensis 1.5-2; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1.5-2; Rhizoma Cyperi 1.5-2; Radix Aucklandiae 1.5-2; Radix Rehmanniae 1.5-2; Radix Et Rhizoma Rhei 1.5-2; Radix Salviae Miltiorrhizae 1.5-2; Fructus Aurantii 1.5-2; Radix Glycyrrhizae 1.5-2 and true yellow Oleum Glycines 500 is with to decide powder an amount of.
4. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 5-5.5; Rhizoma Atractylodis Macrocephalae 2-2.5; Spina Gleditsiae 2-2.5; Rhizoma Pinelliae 2-2.5; Cortex Magnoliae Officinalis 2-2.5; Radix Angelicae Sinensis 2-2.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 2-2.5; Rhizoma Cyperi 2-2.5; Radix Aucklandiae 2-2.5; Radix Rehmanniae 2-2.5; Radix Et Rhizoma Rhei 2-2.5; Radix Salviae Miltiorrhizae 2-2.5; Fructus Aurantii 2-2.5; Radix Glycyrrhizae 2-2.5 and true yellow Oleum Glycines 500 is with to decide powder an amount of.
5. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 5.5-6; Rhizoma Atractylodis Macrocephalae 2.5-3; Spina Gleditsiae 2.5-3; Rhizoma Pinelliae 2.5-3; Cortex Magnoliae Officinalis 2.5-3; Radix Angelicae Sinensis 2.5-3; Cortex cinnamomi japonici (Ramulus Cinnamomi) 2.5-3; Rhizoma Cyperi 2.5-3; Radix Aucklandiae 2.5-3; Radix Rehmanniae 2.5-3; Radix Et Rhizoma Rhei 2.5-3; Radix Salviae Miltiorrhizae 2.5-3; Fructus Aurantii 2.5-3; Radix Glycyrrhizae 2.5-3 and true yellow Oleum Glycines 500 is with to decide powder an amount of.
6. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 6-6.5; Rhizoma Atractylodis Macrocephalae 3-3.5; Spina Gleditsiae 3-3.5; Rhizoma Pinelliae 3-3.5; Cortex Magnoliae Officinalis 3-3.5; Radix Angelicae Sinensis 3-3.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 3-3.5; Rhizoma Cyperi 3-3.5; Radix Aucklandiae 3-3.5; Radix Rehmanniae 3-3.5; Radix Et Rhizoma Rhei 3-3.5; Radix Salviae Miltiorrhizae 3-3.5; Fructus Aurantii 3-3.5; Radix Glycyrrhizae 3-3.5 and true yellow Oleum Glycines 550 is with to decide powder an amount of.
7. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 6.5-7; Rhizoma Atractylodis Macrocephalae 3.5-4; Spina Gleditsiae 3.5-4; Rhizoma Pinelliae 3.5-4; Cortex Magnoliae Officinalis 3.5-4; Radix Angelicae Sinensis 3.5-4; Cortex cinnamomi japonici (Ramulus Cinnamomi) 3.5-4; Rhizoma Cyperi 3.5-4; Radix Aucklandiae 3.5-4; Radix Rehmanniae 3.5-4; Radix Et Rhizoma Rhei 3.5-4; Radix Salviae Miltiorrhizae 3.5-4; Fructus Aurantii 3.5-4; Radix Glycyrrhizae 3.5-4 and true yellow Oleum Glycines 550 is with to decide powder an amount of.
8. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 7-8; Rhizoma Atractylodis Macrocephalae 4-5; Spina Gleditsiae 4-5; Rhizoma Pinelliae 4-5; Cortex Magnoliae Officinalis 4-5; Radix Angelicae Sinensis 4-5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 4-5; Rhizoma Cyperi 4-5; Radix Aucklandiae 4-5; Radix Rehmanniae 4-5; Radix Et Rhizoma Rhei 4-5; Radix Salviae Miltiorrhizae 4-5; Fructus Aurantii 4-5; Radix Glycyrrhizae 4-5 and true yellow Oleum Glycines 600 is with to decide powder an amount of.
9. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being to be processed by following raw material medicaments: get Radix Astragali 30g; Each 15g of the Rhizoma Atractylodis Macrocephalae, Spina Gleditsiae, the Rhizoma Pinelliae, Cortex Magnoliae Officinalis, Radix Angelicae Sinensis, Cortex cinnamomi japonici (Ramulus Cinnamomi), Rhizoma Cyperi, the Radix Aucklandiae, Radix Rehmanniae, Radix Et Rhizoma Rhei, Radix Salviae Miltiorrhizae, Fructus Aurantii and Radix Glycyrrhizae; True yellow Oleum Glycines 2500g is with to decide powder an amount of.
10. make like claim 1 or 2 or 3 or 4 or 5 or 6 or 7 or the plaster of 8 or 9 described treatment cyclomastopathy, its manufacture method is described below:
To make as follows by the Chinese medicine of above-mentioned weight proportion: with true yellow Oleum Glycines medicine is soaked in the oil, soak time is 5 days springs, 3 days summers, 5 days autumns, 10 days winters; Wait to soak day full after, put it in the black earth pot, slow fire endures that to make medicine withered, floats to medicine; Filter gruffs with the sterilization calico then, make medicine oil, to going into to decide powder 500g, promptly medicine oil is 2:1 with the ratio of deciding powder with the every 1000g of medicine oil; The slow fire of useing force boils 7-8 hour, and ceaselessly stirs to thick with Ramulus Persicae, Ramulus Salicis Babylonicae, Ramulus Mori or Rumalus sophorae, splashes into Cheng Zhu in the water, takes in then in the porcelain; And porcelain put into cold water, and soaking seven days, releasing fire-toxin is subsequent use.
CN2010101383563A 2010-04-02 2010-04-02 Plaster for treating hyperplasia of mammary glands Expired - Fee Related CN101810745B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010101383563A CN101810745B (en) 2010-04-02 2010-04-02 Plaster for treating hyperplasia of mammary glands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010101383563A CN101810745B (en) 2010-04-02 2010-04-02 Plaster for treating hyperplasia of mammary glands

Publications (2)

Publication Number Publication Date
CN101810745A CN101810745A (en) 2010-08-25
CN101810745B true CN101810745B (en) 2012-01-25

Family

ID=42618205

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010101383563A Expired - Fee Related CN101810745B (en) 2010-04-02 2010-04-02 Plaster for treating hyperplasia of mammary glands

Country Status (1)

Country Link
CN (1) CN101810745B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106474305A (en) * 2016-12-02 2017-03-08 朱日朝 A kind of Chinese medicine external powder for treating cyclomastopathy

Also Published As

Publication number Publication date
CN101810745A (en) 2010-08-25

Similar Documents

Publication Publication Date Title
CN103463528A (en) Traditional Chinese medicine composition for treating chronic eczema
CN102000301A (en) Traditional Chinese medicine composite for treating mammitis and lobular hyperplasia of mammary gland and preparation method thereof
CN104771666A (en) Traditional Chinese medicine composition for treating psoriasis
CN103272096A (en) Traditional Chinese medicine for treating dysmenorrhea
CN102512632A (en) Chinese herbal composition for treating abnormal menstruation
CN101987138A (en) Chinese medicinal preparation for treating impotence
CN101693101A (en) Lanceolata radish seed decoction for treating chronic gastritis
CN102048899A (en) Traditional Chinese medicine preparation for treating impotence
CN103071028A (en) Traditional Chinese medicinal composition for treating anaphylactoid purpura
CN102397329A (en) Medicament for treating intestine and stomach flu
CN103211980A (en) Traditional Chinese medicine composition for treatment of yin deficiency and yang excess
CN103623385B (en) A kind of Chinese medicine for the treatment of oral ulcer
CN102302622A (en) Traditional Chinese medicine used for treating radiodermatitis
CN102895610A (en) Medicine for treating edema
CN103893521A (en) Traditional Chinese medicine for treating chronic gastritis and preparation method thereof
CN101810745B (en) Plaster for treating hyperplasia of mammary glands
CN103768306A (en) Traditional Chinese medicinal composition for preventing and treating asthma and preparation method thereof
CN102988650A (en) Medicament for treating chronic nephritis and preparation method of medicament
CN103495103B (en) Medicament for promoting digestion and strengthening spleen
CN105233208A (en) Traditional Chinese medicine preparation for treating heart failure
CN101658652A (en) Chinese medicinal preparation for treating chronic appendicitis
CN104042839A (en) Traditional Chinese medicine composition for treating tinea versicolor
CN102145139A (en) Traditional Chinese medicinal composition for treating fissured tongues
CN103372137A (en) Traditional Chinese medicine preparation for treating lung tumor and lung cancer of human body
CN103432544B (en) Decoction for treating upper gastrointestinal hemorrhage

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120125

Termination date: 20170402